225 related articles for article (PubMed ID: 18777585)
1. Recurrence of cholestatic liver disease after living donor liver transplantation.
Tamura S; Sugawara Y; Kaneko J; Togashi J; Matsui Y; Yamashiki N; Kokudo N; Makuuchi M
World J Gastroenterol; 2008 Sep; 14(33):5105-9. PubMed ID: 18777585
[TBL] [Abstract][Full Text] [Related]
2. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database.
Kashyap R; Safadjou S; Chen R; Mantry P; Sharma R; Patil V; Maloo M; Ryan C; Marroquin C; Barry C; Ramaraju G; Maliakkal B; Orloff M
J Gastrointest Surg; 2010 Sep; 14(9):1362-9. PubMed ID: 20617395
[TBL] [Abstract][Full Text] [Related]
3. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis.
Kashyap R; Mantry P; Sharma R; Maloo MK; Safadjou S; Qi Y; Jain A; Maliakkal B; Ryan C; Orloff M
J Gastrointest Surg; 2009 Aug; 13(8):1480-6. PubMed ID: 19430850
[TBL] [Abstract][Full Text] [Related]
5. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
[TBL] [Abstract][Full Text] [Related]
6. Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.
Choudhary NS; Saigal S; Thummala S; Saraf N; Rastogi A; Bhangui P; Srinivasan T; Yadav SK; Nundy S; Soin AS
J Clin Exp Hepatol; 2020; 10(5):442-447. PubMed ID: 33029052
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of primary sclerosing cholangitis after living donor liver transplantation.
Tamura S; Sugawara Y; Kaneko J; Matsui Y; Togashi J; Makuuchi M
Liver Int; 2007 Feb; 27(1):86-94. PubMed ID: 17241386
[TBL] [Abstract][Full Text] [Related]
8. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis.
Morioka D; Egawa H; Kasahara M; Jo T; Sakamoto S; Ogura Y; Haga H; Takada Y; Shimada H; Tanaka K
Liver Transpl; 2007 Jan; 13(1):80-90. PubMed ID: 16964594
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC.
Maheshwari A; Yoo HY; Thuluvath PJ
Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation.
Duclos-Vallée JC
Acta Gastroenterol Belg; 2005; 68(3):331-6. PubMed ID: 16268420
[TBL] [Abstract][Full Text] [Related]
11. The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.
Patel YA; Henson JB; Wilder JM; Zheng J; Chow SC; Berg CL; Knechtle SJ; Muir AJ
Clin Transplant; 2018 Oct; 32(10):e13388. PubMed ID: 30136315
[TBL] [Abstract][Full Text] [Related]
12. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
[TBL] [Abstract][Full Text] [Related]
13. Zero Mortality in Living-Donor Liver Transplantation for Primary Biliary Cholangitis in Patients With a Meld Score of <20.
Yanagaki M; Onda S; Furukawa K; Taniai T; Haruki K; Akaoka M; Shirai Y; Matsumoto M; Gocho T; Uwagawa T; Ikegami T
Transplant Proc; 2023 May; 55(4):898-900. PubMed ID: 37095011
[TBL] [Abstract][Full Text] [Related]
14. Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database.
Ziogas IA; Alexopoulos SP; Matsuoka LK; Geevarghese SK; Gorden LD; Karp SJ; Perkins JD; Montenovo MI
Clin Transplant; 2020 Oct; 34(10):e14031. PubMed ID: 33427333
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation in chronic cholestatic conditions.
Milkiewicz P; Wunsch E; Elias E
Front Biosci (Landmark Ed); 2012 Jan; 17(3):959-69. PubMed ID: 22201783
[TBL] [Abstract][Full Text] [Related]
16. Liver Transplantation for Cholestatic Liver Diseases in Adults.
Khungar V; Goldberg DS
Clin Liver Dis; 2016 Feb; 20(1):191-203. PubMed ID: 26593299
[TBL] [Abstract][Full Text] [Related]
17. Response to endoscopic therapy for biliary anastomotic strictures in deceased versus living donor liver transplantation.
Chan CH; Donnellan F; Byrne MF; Coss A; Haque M; Wiesenger H; Scudamore CH; Steinbrecher UP; Weiss AA; Yoshida EM
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):488-93. PubMed ID: 24103278
[TBL] [Abstract][Full Text] [Related]
18. Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living-donor-dominant program.
Kasahara M; Katono M; Schlegel A; Kubota T; Nakazato Y; Uchida H; Shimizu S; Yanagi Y; Takeda M; Fukuda A; Sakamoto S
Pediatr Transplant; 2019 Dec; 23(8):e13578. PubMed ID: 31535772
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation in PBC and PSC: indications and disease recurrence.
Carbone M; Neuberger J
Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):446-54. PubMed ID: 21459072
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Outcomes of Living-Donor Liver Transplantation for Primary Biliary Cirrhosis: A Japanese Multicenter Study.
Egawa H; Sakisaka S; Teramukai S; Sakabayashi S; Yamamoto M; Umeshita K; Uemoto S
Am J Transplant; 2016 Apr; 16(4):1248-57. PubMed ID: 26731039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
